App aims to keep IBD patients on track, cut hospital trips
NCT ID NCT05316584
First seen Jan 11, 2026 · Last updated May 19, 2026 · Updated 17 times
Summary
This study tests a remote monitoring system (app and medication reminders) for people with inflammatory bowel disease (IBD) starting a new oral or injectable treatment. About 123 adults will use the system or standard care for 12 months to see if it improves medication adherence, disease control, and reduces emergency visits. The goal is to help patients manage their condition better at home.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
New York University
New York, New York, 10016, United States
-
University of Cincinnati College of Medicine
Cincinnati, Ohio, 45267, United States
-
University of Maryland School of Medicine
Baltimore, Maryland, 21201, United States
-
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27599-7080, United States
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37212, United States
Conditions
Explore the condition pages connected to this study.